Blackstone Inc Portage Biotech Inc. Call Options Transaction History
Blackstone Inc
- $21.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTG
# of Institutions
3Shares Held
28.4KCall Options Held
0Put Options Held
0About PORTAGE BIOTECH INC.
- Ticker PRTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,943,700
- Market Cap $75.4M
- Description
- Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...